Herbalife Expects Q3 Net Sales To Decline (4.5)% To 0% Y/Y; Revises FY24 Sales Growth Outlook To (3.5)% To +1.5% (Prior View 0% To +5%)
Portfolio Pulse from Benzinga Newsdesk
Herbalife expects Q3 net sales to decline between 4.5% and 0% year-over-year and revises its FY24 sales growth outlook to a range of -3.5% to +1.5%, down from the previous range of 0% to +5%. The company also revised its full-year 2024 guidance, reducing net sales, raising adjusted EBITDA, and reaffirming capital expenditures.
July 31, 2024 | 8:40 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Herbalife has revised its Q3 and FY24 outlook, expecting a decline in Q3 net sales and lowering its FY24 sales growth outlook. However, the company has raised its adjusted EBITDA and reaffirmed its capital expenditures.
The downward revision in sales outlook for both Q3 and FY24 is likely to negatively impact investor sentiment and the stock price in the short term. However, the raised adjusted EBITDA and reaffirmed capital expenditures may provide some support.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100